|
US5360897A
(en)
|
1981-08-31 |
1994-11-01 |
The University Of Rochester |
Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
|
|
CA1247080A
(en)
|
1983-03-08 |
1988-12-20 |
Commonwealth Serum Laboratories Commission |
Antigenically active amino acid sequences
|
|
SE8405493D0
(sv)
|
1984-11-01 |
1984-11-01 |
Bror Morein |
Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
|
|
US5078996A
(en)
|
1985-08-16 |
1992-01-07 |
Immunex Corporation |
Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
WO1990014837A1
(en)
|
1989-05-25 |
1990-12-13 |
Chiron Corporation |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
IT1253009B
(it)
|
1991-12-31 |
1995-07-10 |
Sclavo Ricerca S R L |
Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
|
|
EP0625910B1
(en)
|
1992-02-11 |
2003-07-23 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Dual carrier immunogenic construct
|
|
DK0616034T3
(da)
|
1993-03-05 |
2005-02-21 |
Wyeth Corp |
Plasmid til fremstilling af CRM-protein og diphtheria toxin
|
|
EP0720485B1
(en)
|
1993-09-22 |
2003-11-19 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
|
|
US5571515A
(en)
|
1994-04-18 |
1996-11-05 |
The Wistar Institute Of Anatomy & Biology |
Compositions and methods for use of IL-12 as an adjuvant
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
BE1008978A5
(fr)
|
1994-12-27 |
1996-10-01 |
Solvay |
Adjuvants pour vaccins.
|
|
DE69628418T2
(de)
|
1995-03-22 |
2004-04-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden
|
|
GB9622159D0
(en)
|
1996-10-24 |
1996-12-18 |
Solvay Sociutu Anonyme |
Polyanionic polymers as adjuvants for mucosal immunization
|
|
GB9622660D0
(en)
|
1996-10-31 |
1997-01-08 |
Biocine Spa |
Immunogenic detoxified mutant toxin
|
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US6936258B1
(en)
|
1999-03-19 |
2005-08-30 |
Nabi Biopharmaceuticals |
Staphylococcus antigen and vaccine
|
|
US7115730B1
(en)
|
1999-04-27 |
2006-10-03 |
Chiron Srl |
Immunogenic detoxified mutant E. coli LT-A-toxin
|
|
US7384640B1
(en)
|
1999-09-30 |
2008-06-10 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant
|
|
HU228264B1
(en)
|
2000-06-08 |
2013-02-28 |
Intercell Ag |
Immunostimulatory oligodeoxynucleotides
|
|
AT410635B
(de)
|
2000-10-18 |
2003-06-25 |
Cistem Biotechnologies Gmbh |
Vakzin-zusammensetzung
|
|
WO2002098368A2
(en)
|
2001-06-07 |
2002-12-12 |
Wyeth Holdings Corporation |
Mutant forms of cholera holotoxin as an adjuvant
|
|
US7332174B2
(en)
|
2001-06-07 |
2008-02-19 |
Wyeth Holdings Corporation |
Mutant forms of cholera holotoxin as an adjuvant
|
|
US20040096461A1
(en)
*
|
2002-07-30 |
2004-05-20 |
Baxter Healthcare Corporation |
Chimeric multivalent polysaccharide conjugate vaccines
|
|
EP1603950A2
(en)
|
2003-03-17 |
2005-12-14 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
|
US20070184072A1
(en)
|
2005-04-08 |
2007-08-09 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
IL308456A
(en)
|
2005-04-08 |
2024-01-01 |
Wyeth Llc |
A multivalent pneumomuroral protein-polysaccharide conjugate preparation
|
|
US7709001B2
(en)
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US7955605B2
(en)
|
2005-04-08 |
2011-06-07 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
PL1866342T3
(pl)
|
2005-04-08 |
2019-04-30 |
Wyeth Llc |
Oddzielanie zanieczyszczeń od polisacharydu Streptococcus pneumoniae przez manipulację pH
|
|
CA2665169C
(en)
|
2006-10-10 |
2017-02-21 |
Wyeth |
Purification of streptococcus pneumoniae type 3 polysaccharides
|
|
HUE039169T2
(hu)
|
2007-03-23 |
2018-12-28 |
Wyeth Llc |
Rövidített tisztítási eljárás Streptococcus pneumoniae tok-poliszacharidok elõállítására
|
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
|
CN104582718B
(zh)
|
2012-10-03 |
2017-10-24 |
诺华股份有限公司 |
免疫原性组合物
|
|
RU2672053C2
(ru)
|
2012-12-20 |
2018-11-09 |
Пфайзер Инк. |
Способ гликоконъюгации
|
|
KR102143534B1
(ko)
*
|
2015-05-04 |
2020-08-12 |
화이자 인코포레이티드 |
B군 스트렙토코쿠스 폴리사카라이드-단백질 접합체, 접합체를 생산하는 방법, 접합체를 포함하는 면역원성 조성물, 및 그의 용도
|
|
EP3316904A1
(en)
*
|
2015-07-01 |
2018-05-09 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic compositions
|
|
US10751402B2
(en)
*
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
EP3638301A1
(en)
*
|
2017-06-16 |
2020-04-22 |
GlaxoSmithKline Biologicals S.A. |
Method of treatment
|
|
EP4203995A1
(en)
*
|
2020-08-26 |
2023-07-05 |
Pfizer Inc. |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|